Change the outlook
for dry eye disease
INDICATIONS AND USAGE
CEQUA™ (cyclosporine ophthalmic solution) 0.09% is a calcineurin inhibitor immunosuppressant
indicated to increase tear production in patients with keratoconjunctivitis sicca (dry eye).
IMPORTANT SAFETY INFORMATION
WARNINGS AND PRECAUTIONS
Potential for Eye Injury and Contamination: To avoid the potential for eye injury and
contamination, advise patients not to touch the vial tip to the eye or other surfaces.
• NCELL helps improve the delivery of cyclosporine
to where it is needed
2,3
• Signi cant improvement in tear production
at 3 months
1
• Signi cant improvement in corneal staining as
early as 1 month
2,4
• In a comfort assessment at 3 minutes post
instillation, 90% (Day 0) and 85% (Day 84)
of patients had no or mild ocular discomfort
4
Visit GetCequa.com to learn more.
Only CEQUA™ features NCELL™, an innovative technology
that helps improve the ocular penetration of cyclosporine
1-3
